Introduction {#S0001}
============

*Acinetobacter baumannii* is an aerobic, non-fermenting, Gram-negative opportunistic pathogen that causes pneumonia, secondary meningitis, and a variety of other infections following incisions or wounds to the skin and soft tissues.[@CIT0001]--[@CIT0003] The ability of *A. baumannii* to survive under a wide range of environmental conditions for a long time ensures this species is a prevalent nosocomial pathogen worldwide, especially in the intensive care, neurosurgery, and burns departments of hospitals.[@CIT0004]--[@CIT0006] Owing to the ability of *A. baumannii* to develop and/or acquire a variety of resistance mechanisms, currently susceptible bacteria may soon evolve into multidrug-resistant *A. baumannii* (MDRAB) that are resistant to a wide variety of antibacterial agents including β-lactams, cephems, carbapenems, aminoglycosides, tetracyclines, fluoroquinolones, and folate pathway inhibitors.[@CIT0007] MDRAB infections can ultimately lead to increased morbidity and mortality.

Genomics analysis revealed that MDRAB contain several large resistance islands that contain 24 genes associated with antibiotic resistance and 16 genes associated with resistance to heavy metal salts or quaternary ammonium compounds commonly used in disinfectants. These resistance genes were reportedly acquired from *Pseudomonas aeruginosa, Salmonella*spp.,*Escherichia coli*, and other Gram-negative bacteria.[@CIT0008] Multiple mechanisms are involved in resistance in *A. baumannii*, including the production of inactivating enzymes, deletion, or mutation of outer membrane proteins, expression of multidrug efflux systems, changing or protecting the target sites of antibacterial agents, and transferring resistance genes through mobile genetic elements.[@CIT0009] The *bla*~oxa-23~ gene is the most common carbapenem resistance gene in MDRAB clinical isolates from most regions of the world. This gene encodes a carbapenem-hydrolyzing class D oxacillinase, and production of this enzyme is not inhibited by clavulanic acid.[@CIT0010]--[@CIT0012] Multidrug efflux systems such as *Ade-ABC* have a tripartite structure comprising an inner membrane component (*AdeA*), an antibacterial agent transport component (*AdeB*), and an outer membrane component (*AdeC*). Resistance to β-lactams, erythromycin, aminoglycosides, tetracyclines, and chloramphenicol is dependent on overexpression of *Ade-ABC*.[@CIT0013]--[@CIT0015] The class 1 integron *int-1* is a three-part bacterial mobile genetic element found in *A. baumannii*. The 5ʹ conserved region of *int-1* encodes a site-specific integrase, the central variable region encodes several gene cassettes, and there is also a 3ʹ conserved region.[@CIT0016] The class 1 integron can capture resistance genes and integrate the associated gene cassettes into the *A. baumannii* genome to generate MDRAB.[@CIT0017] Insertion sequence common region 1(*ISCR-1*) is a special mobile genetic element that is similar to IS91-like and shares a sustaining transpose rolling-circle mechanism.[@CIT0018] Like the class 1 integron, *ISCR-1* has the ability to capture resistance genes from other bacteria.[@CIT0019] The ability to detect *OXA-23, Ade-ABC*, class 1 integron, and *ISCR-1* resistance genes is crucial for identifying and treating MDRAB.

Recent improvements in the molecular methods used to detect resistance genes have decreased turnaround time and increased the specificity and sensitivity of testing procedures.[@CIT0020],[@CIT0021] There are existing molecular assays that can detect *bla*~oxa-23~, *Ade-B, int-1*, and *ISCR-1*, but these are time-consuming and unable to detect all four resistance genes in a single assay.[@CIT0019],[@CIT0022] Although detection of these genes may not revolutionize clinical treatment, their identification will assist epidemiological investigations and help to control hospital-acquired infections. Our objective was to develop a single-tube multiplex PCR assay that can detect these four genes simultaneously using a dedicated high resolution melting (HRM) assay reagent. The established method was used to characterize the four resistance genes in MDRAB isolates collected in 2014 from the Third Affiliated Hospital of Southern Medical University in southern China.

Materials and methods {#S0002}
=====================

Definition of MDRAB {#S0002-S2001}
-------------------

MDRAB is defined as non-susceptible to at least one agent in ≥3 antimicrobial categories of aminoglycosides, antipseudomonal carbapenems, antipseudomonal fluoroquinolones, antipseudomonal penicillins + β-lactamase inhibitors, extended-spectrum cephalosporins, folate pathway inhibitors, penicillins + β-lactamase inhibitors, and tetracyclines.[@CIT0023]

Bacterial strains and antibiotic susceptibility testing {#S0002-S2002}
-------------------------------------------------------

After exclusion of strains isolated repeatedly from one patient, a total of 87 MDRAB strains were isolated from various clinical specimens at the Third Affiliated Hospital of Southern Medical University, a comprehensive teaching hospital in southern China. All isolates were identified and tested for drug sensitivity using Microscan Walkaway 40 Plus (Beckman Coulter, West Sacramento, USA), and the results were interpreted according to the Clinical and Laboratory Standards Institute 2017 guidelines.

DNA isolation {#S0002-S2003}
-------------

Total DNA was extracted from well-established colonies using the Rapid Ezup Column Genomic DNA Extraction Kit (Sangon Biotech, Shanghai, China) according to the recommendations of the manufacturer. DNA was eluted with 100 μL CE buffer and stored at --80°C.

Primer design {#S0002-S2004}
-------------

With reference to sequences from the NCBI database (<http://www.ncbi.nlm.nih.gov/gene/>), we designed two pairs of primers for each of the four genes, one of which was used for preliminary screening of the target gene, and another that was used to establish the multiplex PCR assay. The four sets of primers used for multiplex PCR were designed to have a similar annealing temperature, and to amplify predicted products of different sizes and melting temperatures ([Table 1](#T0001){ref-type="table"}).Table 1Primers used in this studyPrimer nameSequence(5ʹ→3ʹ)^a^Primer *T*~m~(℃)^b^Product size^b^Product predicted *T*~m~(℃)^b^Product actual T~m~(℃)^c^Preliminary primersOXA-23 FAGGTCATTTACCGCTTGG54.1396 bpNDNDOXA-23 RTCCATCTGGCTGCTCAAC53.1Ade-B FAGATTTCAAAGAGCGGACTA52.2263 bpNDNDAde-B RCTTGTGGCAACCCTTCAT53.3int-1 FGCAAGGTTTCGGTCTCCAC57.5477 bpNDNDint-1 RAGAACCACGGCCAGGAAT57.2ISCR1 FAATCGCCCACTCAAACAA54.1576 bpNDNDISCR1 RCATCTTCGGCATAGACACC53.2Primers for establishing the multiplex PCR with HRM assayOXA-23 FAAACGTATTGGTTTCGGTAAT54.0139 bp82.079.5OXA-23 RTTTCACTAAATGGAAGCTGTG53.3Ade-B FTATTGGCTACGAGTGGACAG53.5390 bp85.182.4Ade-B RCCACAGGTAAATGCAAGTGA54.1int-1 FCTTACGAACCGAACAGGC53.6234 bp91.590.3int-1 RCGAGGTCTTCCGATCTCC54.5ISCR1 FCGCTAAATCTCAATGTCCAC53.1187 bp88.687.1ISCR1 RGCATCACGCTCCAAAATC54.0[^2][^3]

Preliminary screening of bla~oxa-23~, *Ade-B*, int-1, and ISCR-1 {#S0002-S2005}
----------------------------------------------------------------

Four sets of preliminary primers were used to characterize the four genes in the 8 of 87 MDRAB isolates. Each 20 μL PCR contained 10 μL of 2× PCR master mix (Generay Biotech, Shanghai, China), 0.6 μL of 10 μM forward and reverse primers, 1.4 μL of template DNA, and 7.4 μL of double-distilled water. Amplification was performed using the following conditions: initial denaturation at 95°C for 3 mins, followed by 40 cycles of denaturation (95°C, 30 s), annealing (56°C for *bla*~oxa-23~, 55°C for *Ade-B*, 59°C for *int-1*, 56°C for *bla*~oxa-23~, 45 s), extension (72°C, 1 min), and a final extension at 72°C for 5 mins. To validate the PCR products they were separated by agarose gel electrophoresis, stained with GoldView ^TM^(nontoxic) and photographed on a UV transilluminator.

DNA sequencing and actual melting temperature (*t*~m~) determination {#S0002-S2006}
--------------------------------------------------------------------

To ensure the specificity of the primers used for the multiplex PCR with HRM assay, the four sets of the primers were used to detect the four genes that were amplified using the preliminary primers. Reactions were similar to the preliminary screening conditions but contained 10 μL of 2× HRM FAST PCR master mix (Kapa Biosystems, Cape Town, South Africa), 0.6 μL of 10 μM forward and reverse primers, 1.4 μL of template DNA, 2 μL of 25 mM Mgcl~2~, and 5.4 μL of double-distilled water. Amplifications were performed as described above but with an annealing temperature of 56°C for all four sets of primers. PCR products were separated by agarose gel electrophoresis and sequenced, and data were analyzed using the Basic Local Alignment Search Tool (BLAST, <http://blast.ncbi.nlm.nih.gov/Blast.cgi>).

In addition to determining the actual melting temperature (*T*~m~) using HRM analysis with the LightScanner System (Idaho Technology Inc., Cape Town, South Africa), melting curves were performed by measuring the decrease in fluorescent signal with increasing temperature by ramping at 0.02°C/s with 25 acquisitions/°C. *T*~m~ is defined as the temperature at which 50% of the amplified product dissociated into single-stranded DNA, and the actual *T*~m~ of the four genes was used as a reference to determine which gene was present in amplification reactions from the isolates.

Development of the multiplex PCR and HRM assay {#S0002-S2007}
----------------------------------------------

Template DNA used in multiplex PCR was a mixture of isolates, and these were tested for the presence of *bla*~oxa-23~, *Ade-B, int-1*, and *ISCR-1*. Multiplex PCR was performed in single-tube 20 μL reactions containing 10 μL of 2× HRM FAST PCR master mix, 0.4 μL of 10 μM forward and reverse primers (total of 3.2 μL), 1.4 μL of compound template DNA, 2 μL of 25 mM Mgcl~2~, and 3.4 μL of double-distilled water. To ensure the sensitivity and specificity of multiplex PCR, annealing was tested at 54°C, 56°C, 58°C, and 60°C. All other reaction conditions were as described above. Melting curves from all multiplex PCR amplification products were generated using a LightScanner System, and products were separated by agarose gel electrophoresis following HRM analysis.

Screening of clinical isolates {#S0002-S2008}
------------------------------

Seventy-nine of the remaining 87 MDRAB strains were screened for the presence of the four genes using the multiplex PCR and HRM assay described above. We also tested for the presence of the four genes using traditional PCR and agarose gel electrophoresis-based methods (one PCR reaction detecting one gene) to verify the accuracy of the multiplex PCR and HRM assay.

Results {#S0003}
=======

Preliminary screening for bla~oxa-23~, *Ade-B*, int-1, and ISCR-1 {#S0003-S2001}
-----------------------------------------------------------------

Preliminary screening of eight MDRAB isolates for the four genes was performed to provide positive controls for developing multiplex PCR of unknown samples. Agarose gel electrophoresis demonstrated the presence of *Ade-B, int-1,* and *ISCR-1* in strain 1, and *bla*~oxa-23~ and *Ade-B* in all of the other seven strains ([Figure 1](#F0001){ref-type="fig"}).Figure 1Agarose gel electrophoresis of the PCR amplification products of the four genes from eight MDRAB isolates using preliminary primers.

DNA sequencing and differentiation of the four genes using HRM curve analysis {#S0003-S2002}
-----------------------------------------------------------------------------

Strains 1 and 2 were used as positive controls for establishing the multiplex PCR with HRM assay. Four sets of the primers were used to detect the four genes in these strains, and agarose gel electrophoresis resulted in bands of 139, 390, 234, and 187 bp as expected ([Figure 2](#F0002){ref-type="fig"}). The BLAST results confirmed that the sequences of the PCR amplification products were the same as those previously published.Figure 2Agarose gel electrophoresis of PCR amplification products of the four genes using multiplex PCR primers.

The PCR amplification products were differentiated by HRM curve analysis. The presence of *bla*~oxa-23~ was revealed by a single dominant peak with a melting temperature of 79.5°C in the melting curve analysis ([Figure 3A](#F0003){ref-type="fig"}), while *Ade-B int-1* and *ISCR-1* corresponded to single dominant peaks at 82.4°C, 90.3°C, and 87.1°C, respectively ([Figure 3B](#F0003){ref-type="fig"}--[D](#F0003){ref-type="fig"}). All melting temperatures were lower than predicted, and differences in the actual melting temperatures allowed the four genes to be easily distinguished by HRM curve analysis ([Figure 4](#F0004){ref-type="fig"}).Figure 3Melting curves of PCR amplification products of the four genes used in HRM analysis. --d\[Fluorescence\]/dT (*y*-axis) is plotted against temperature (C) on the *x*-axis. The melting curves of *bla*~oxa-23~, *Ade-B, int-1*, and *ISCR-1* are shown in **A**, **B**, **C**, and **D**, respectively.**Abbreviation:** HRM, high resolution melting.Figure 4Melting curves of the four genes form HRM analysis plotted on the same graph.**Abbreviation:** HRM, high resolution melting.

Development of the multiplex PCR and HRM assay {#S0003-S2003}
----------------------------------------------

Multiplex PCR amplification products with different annealing temperatures were separated by agarose gel electrophoresis and photographed, and melting curve analysis was performed after electrophoresis. Multiplex PCR amplification generated four products with sizes corresponding to the four genes ([Figure 5A](#F0005){ref-type="fig"}). Additionally, HRM analysis showed that the melting curves of multiplex PCR amplification products produced four peaks with the same melting temperature as the four genes ([Figure 5B](#F0005){ref-type="fig"}--[C](#F0005){ref-type="fig"}). Agarose gel electrophoresis showed that the *bla*~oxa-23~ amplification product decreased with increasing annealing temperature ([Figure 5A](#F0005){ref-type="fig"}), and the melting curve of *bla*~oxa-23~ similarly decreased with increasing annealing temperature ([Figure 5D](#F0005){ref-type="fig"}). Since the *bla*~oxa-23~ peak was the lowest of all four peaks, we selected 54°C as the most appropriate annealing temperature to improve the sensitivity of *bla*~oxa-23~ detection in the multiplex PCR with HRM assay.Figure 5(**A**) Representative agarose gel electrophoresis of multiplex PCR products of the four genes with different annealing temperatures amplified in a single tube. 1--4= annealing temperatures of 54°C, 56°C, 58°C, and 60°C, respectively. (**B**) Representative melting curves of the single-tube multiplex PCR with HRM assay performed with different annealing temperatures. (**C**) Melting curves of the four genes (1--4) and that of the multiplex PCR with HRM assay (5) plotted on a single graph. (**D**) Representative enlargement of *bla*~oxa-23~ peaks from melting curves derived from a single-tube multiplex PCR with HRM assay with different annealing temperatures. 1--4= annealing temperatures of 54°C, 56°C, 58°C, and 60°C, respectively.

Screening clinical isolates for the presence of the four genes {#S0003-S2004}
--------------------------------------------------------------

Seventy-nine MDRAB clinical isolates were screened for the presence of the four genes using the multiplex PCR with HRM assay. From the melting curves, the HRM assay identified *bla*~oxa-23~ and *Ade-B* in 73/79 isolates, while *int-1* was present one isolate, both *int-1* and *ISCR-1* were present in two isolates, and *Ade-B, int-1* and *ISCR-1* were present in three isolates ([Figure 6](#F0006){ref-type="fig"}). No isolates were found to be carried all four genes ([Figure 6](#F0006){ref-type="fig"}). The presence of the four genes detected using the multiplex PCR with HRM assay was consistent with data from traditional methods ([Figure7](#F0007){ref-type="fig"}, [Table 2](#T0002){ref-type="table"}).Table 2Presence of the four genes in clinical isolates detected by multiplex PCR with HRM assay and traditional methodGeneIsolates\
(Detection bymultiplex PCR with HRM assay)Isolates\
(Detection by traditional method)*bla*~oxa-23~ and *Ade-B*7373*int-1*11*int-1* and *ISCR-1*22*Ade-B, int-1* and *ISCR-1*33Total7979[^4] Figure 6Melting curves of the four genes detected in 79 clinical isolates using the single-tube multiplex PCR with HRM assay.**Abbreviation:** HRM, high resolution melting.Figure 7(**A**) Agarose gel electrophoresis of the resistance gene *bla*~oxa-23~ in 79 clinical isolates. (**B**) Agarose gel electrophoresis of the resistance gene *int-1* in 79 clinical isolates. (**C**) Agarose gel electrophoresis of the resistance gene *ISCR-1* in 79 clinical isolates. (**D**) Agarose gel electrophoresis of the resistance gene *Ade-B* in 79 clinical isolates.

Discussion {#S0004}
==========

*A. baumannii* causes nosocomial infections in hospitals and health care departments and is difficult to treat in multidrug-resistant organisms that often carry *OXA-23, Ade-ABC*, Class 1 integron, and *ISCR-1*.[@CIT0009],[@CIT0024] Accurate and rapid detection of *bla*~oxa-23~, *Ade-B, int-1*, and *ISCR-1* in clinical microbiology laboratories is important for prevention and treatment of MDRAB.[@CIT0025] Conventional assays for screening these *genes* are expensive and time-consuming. In contrast, HRM analysis is a rapid, cost-effective, and high-throughput method. We, therefore, sought to develop a rapid assay for detecting these genes without the need to perform agarose gel electrophoresis in this study.

We designed two sets of primers for each gene and PCR amplification products were sequenced to ensure the specificity of the multiplex PCR with HRM assay. The melting temperatures of the amplified products were different enough to allow us to distinguish between them.

Compared with traditional phenotypic assays, our multiplex PCR with HRM assay has a number of advantages; (1) It is significantly faster and more high-throughput. All four genes are detected simultaneously in the multiplex PCR with HRM assay in a single tube, minimizing contamination and improving efficiency since an agarose gel electrophoresis step is not required. The multiplex PCR with HRM assay could test 96 clinical isolates in 2 hrs 30 mins. (2) The novel assay is cost-effective. The approximate cost of this assay from DNA template extraction to multiplex PCR with HRM analysis is \$2 per sample for the detection of all four genes. (3) The novel assay is non-destructive and environmentally friendly since no harmful ethidium bromide is used because an agarose gel electrophoresis step is not performed.

The four genes are known to play an important role in the evolution if resistance in *A. baumannii*, and in MDRAB in particular. In the 79 clinical isolates tested, *bla*~oxa-23~ and *Ade-B* were the most common, in accordance with published literature.[@CIT0026],[@CIT0027] Our results also demonstrate the co-existence of *ISCR-1* and *int-1* in bacteria. This may be related to the fact that ISCR1 can insert DNA into the 3ʹ conserved regions of class 1 integrons to generate complex class 1 integrons carrying the sul1, resX, and trIb resistance genes.[@CIT0024],[@CIT0028]

In conclusion, we have developed a single-tube multiplex PCR with HRM assay which can reliably detect the presence of *bla*~oxa-23~, *Ade-B, int-1*, and *ISCR-1* separately or in combination. This assay is rapid, cost-effective, non-destructive, easy to set-up, and has high-throughput in nature.
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